Some low-income, uninsured patients aren't referred for colonoscopy

December 13, 2016

(HealthDay)—Many low-income and uninsured patients don't have a follow-up colonoscopy after abnormal results on a colon cancer screening test—even if they're in a "safety net" health program, a new study finds.

A health system provides significant care to vulnerable , regardless of their income. This study included more than 2,200 such patients, ages 50 to 75, in the San Francisco Health Network. This safety net system includes several hospitals and clinics in the area.

All of the study participants had positive findings on a fecal blood test between April 2012 and February 2015.

A fecal blood test is a noninvasive exam that checks for blood in the stool, a possible indication of colon cancer. If blood is detected, the risk of colon cancer is about 10 times higher than for someone who doesn't have in their stool, the researchers said. That's why a follow-up colonoscopy within a year is recommended.

Of the people in the study, 56 percent had a colonoscopy within a year—on average, within six months. Women were more likely than men to get the test, and married patients were more likely than single, separated or divorced patients to have a colonoscopy.

Thirteen percent were never referred for follow-up. Within this group, nearly half of them did not have documentation about their abnormal result or counseling on the increased risk of , the study found.

Of the patients referred and scheduled for a colonoscopy, 25 percent missed their appointment. Almost two-thirds lacked follow-up documentation or counseling.

The research was led by Dr. Rachel Issaka, a gastroenterology fellow at the University of California, San Francisco. The study also found that patients with other illnesses or illicit substance use were less likely to be referred or make their appointments.

The findings suggest that a multilevel approach is needed to increase follow-up colonoscopy rates in this group of patients, the researchers said in a university news release.

The study was published online Dec. 13 in The American Journal of Gastroenterology.

Explore further: CRC detected after colonoscopy often located in proximal colon

More information: The U.S. National Cancer Institute has more on colon cancer screening.

Related Stories

CRC detected after colonoscopy often located in proximal colon

November 10, 2016
(HealthDay)—Colorectal cancer (CRC) detected after colonoscopy examination is more often located in the proximal colon and more likely to have DNA mismatch repair deficiency (dMMR), according to a study published in the ...

Small study supports new stool-based colon cancer test

April 19, 2016
(HealthDay)—A new, but small, study finds more evidence that a recently approved, stool-based colon cancer test may be effective for certain patients.

Study: Colonoscopy after 75 may not be worth it

September 26, 2016
(HealthDay)—A colonoscopy can find and remove cancerous growths in the colon, but it may not provide much cancer prevention benefit after the age of 75, a new study suggests.

Study finds stool test effective for detecting colon cancer

January 26, 2016
(HealthDay)—Tests for blood in the stool can consistently detect colon cancer when used on an annual basis, and they are effective even in the second, third and fourth years of screening, a new study says.

Time between positive fecal blood test and colonoscopy varies widely

February 3, 2016
Patients who received positive fecal blood test results as part of the screening process for colorectal cancer experienced wide variations in the time between a positive result and a follow-up colonoscopy across four U.S. ...

Nurse navigators may aid colon cancer screening follow-up

November 10, 2014
Group Health patients with a positive screening test for colon cancer (a stool test or sigmoidoscopy) tended to be more likely to get the recommended follow-up test, a diagnostic colonoscopy, if nurse navigators contacted ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.